Ataturk University

atauni.edu.tr

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

432

Active

107

Phase 3

2

Total enrollment

46,074

Pipeline matrix

Showing 16 of 16 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Intrathecal Morphine3
Bupivacaine14
Propofol2
Bupivacaine Infiltration1
single nucleotide polymorphism1
Sevoflurane1
Bupivacaine-Lidocaine Combination1
Dexmedetomidine1
Ibuprofen 600 mg1
diclofenac sodium1
Trocar-Site Bupivacaine Infiltration1
Intraperitoneal Bupivacaine spray1
Biodentine1
15 ml Bupivacaine Hcl 0.25%1
20 mL bupivacaine 0.25%1
Toluidine Blue O1

Next readouts

  • 2025-07-10
  • 2025-11-07
  • 2026-04-01
  • 2026-05-02
  • 2026-06-01
  • 2026-06-01
  • 2026-06-15
  • 2026-08
  • 2026-08-01
  • 2026-12-01

Top conditions

  • Analgesia14
  • Anxiety14
  • Pain13
  • Postoperative Pain10
  • Stress9
  • Pain, Acute9
  • Periodontitis8
  • Labor Pain7

Frequently asked questions about Ataturk University

How many clinical trials does Ataturk University have on ClinicalTrials.gov?
Ataturk University is listed as the lead sponsor on 432 clinical trials in ClinicalTrials.gov, 107 of which are currently active (recruiting, enrolling, or ongoing).
How many of Ataturk University's trials are in Phase 3?
2 of Ataturk University's trials are in Phase 3, spread across 16 active drug programs.
What therapeutic areas does Ataturk University focus on?
Ataturk University's most-studied conditions on ClinicalTrials.gov are Analgesia, Anxiety, Pain, Postoperative Pain, Stress.
When are Ataturk University's next clinical trial readouts?
Ataturk University has 10 upcoming primary-completion readouts tracked here; the soonest is “Effect of Genetic Polymorphisms on Response to Preoperative NSAIDs in Endodontic Postoperative Pain Management”, expected around 2025-07-10.